These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1351157

  • 1. Loss of taste and terbinafine.
    Juhlin L.
    Lancet; 1992 Jun 13; 339(8807):1483. PubMed ID: 1351157
    [No Abstract] [Full Text] [Related]

  • 2. Terbinafine and taste loss.
    Veraldi S, Pontini P, Serini SL.
    G Ital Dermatol Venereol; 2016 Jun 13; 151(3):308-9. PubMed ID: 27176083
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Terbinafine-induced ageusia and hyposmia].
    Villota Hoyos R, González-Ruiz M.
    Aten Primaria; 1999 Feb 15; 23(2):102-3. PubMed ID: 10081177
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Objective assessment of terbinafine-induced taste loss.
    Doty RL, Haxel BR.
    Laryngoscope; 2005 Nov 15; 115(11):2035-7. PubMed ID: 16319619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Loss of taste and terbinafine.
    Back D.
    Lancet; 1992 Jul 25; 340(8813):252. PubMed ID: 1353184
    [No Abstract] [Full Text] [Related]

  • 10. Persistent impairment of taste associated with terbinafine.
    Duxbury AJ, Oliver RJ, Pemberton MN.
    Br Dent J; 2000 Mar 25; 188(6):295-6. PubMed ID: 10800234
    [Abstract] [Full Text] [Related]

  • 11. Persistent impairment of taste resulting from terbinafine.
    Bong JL, Lucke TW, Evans CD.
    Br J Dermatol; 1998 Oct 25; 139(4):747-8. PubMed ID: 9892929
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Taste loss to terbinafine: a case-control study of potential risk factors.
    Stricker BH, Van Riemsdijk MM, Sturkenboom MC, Ottervanger JP.
    Br J Clin Pharmacol; 1996 Sep 25; 42(3):313-8. PubMed ID: 8877021
    [Abstract] [Full Text] [Related]

  • 15. [Loss of taste during administration of terbinafine].
    Dekker PJ.
    Ned Tijdschr Geneeskd; 1993 Mar 20; 137(12):616-7. PubMed ID: 8459865
    [No Abstract] [Full Text] [Related]

  • 16. [Agranulocytosis during a treatment with terbinafine].
    Barete S, Bissuel F, Longuet P, Pocidalo MA, Leport C, Vildé JL.
    Rev Med Interne; 1997 Mar 20; 18(3):258-9. PubMed ID: 9173473
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Terbinafine and fixed drug eruption.
    Munn SE, Russell Jones R.
    Br J Dermatol; 1995 Nov 20; 133(5):815-6. PubMed ID: 8555044
    [No Abstract] [Full Text] [Related]

  • 19. Hepatitis associated with terbinafine treatment.
    Lowe G, Green C, Jennings P.
    BMJ; 1993 Jan 23; 306(6872):248. PubMed ID: 8443524
    [No Abstract] [Full Text] [Related]

  • 20. Terbinafine: taste and smell disorders.
    Prescrire Int; 2013 Oct 23; 22(142):244. PubMed ID: 24298595
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.